Cited by 31Alzheimer's disease research and treatmentsDementia and Cognitive Impairment ResearchNeuroinflammation and Neurodegeneration Mechanisms

Along the way to a neurofibrillary tangle: a look at the structure of tau

Kosik, Kenneth S., Kowall, Neil W., McKee, Ann·1989·Annals of Medicine

Abstract

We report our ongoing work to characterize the molecular nature of neurofibrillary tangles (NFT). An epitope map of tau protein using monoclonal antibodies that crossreact with NFT reveals the presence of epitopes that span the entire tau molecule from the amino terminus to the carboxy terminus. Several antibodies that recognize tau protein including Alz50 do not recognize primary amino acid sequence but are directed either against a post-translational modification or a complex higher order structure. The importance of tau protein in the development of the pathology is underscored by the extent of the tau-reactive neuritic lesions. These dystrophic neurites or "curly fibers" extend well beyond the classical distributions of the senile plaques and NFT. Furthermore, the neuropil lesion is considerably more extensive than either the senile plaques or neurofibrillary tangles. One of the features of the dystrophy in Alzheimer's disease is widespread neuronal sprouting characteristic of dystrophic neurites and tangle-bearing cells.

Integrity signals

Registry

Crossref · 10.3109/07853898909149195

Cites

32 of 32 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Tauopathies are neurodegenerative diseases characterized by pathological accumulation of hyper-phosphorylated tau in paired helical filaments or neurofibrillary tangles within neurons and glia of affected brain regions, leading to cell death.

    “Tauopathies are neurodegenerative diseases characterized by aberrant forms of tau protein accumulation leading to neuronal death in focal brain areas.”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Kosik, K. S., Kowall, N. W., & McKee, A.
Affiliations
Brigham and Women's Hospital (US)
Venue
Annals of Medicine
Published
1989-01
Volume
21
Issue
2
Pages
109-112
ISSN
  • 0785-3890 (ISSN-L)
  • 1365-2060
OpenAlex
W1988360179
Cited by
31
References
32
Citations by year
2023: 3 · 2022: 1 · 2021: 1 · 2020: 1 · 2019: 2 · 2018: 3 · 2017: 1 · 2016: 1 · 2015: 1 · 2014: 1
FWCI
0.26
Type
journal article
Language
en
Open access
closed
Locations
  • Annals of Medicine (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
Keywords
tau protein, neurofibrillary tangles, epitope mapping, monoclonal antibodies, post-translational modification, protein higher-order structure, dystrophic neurites, amyloid plaques, nerve sprouting, Alzheimer's disease pathology
MeSH terms
Alzheimer Disease, Amyloidosis, Antibodies, Monoclonal, Cross Reactions, Dendrites, Humans, Microtubule-Associated Proteins, Nerve Tissue Proteins, Neurofibrils, Protein Processing, Post-Translational, tau Proteins

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review